Skip to content

Supporting optimal; value-based; and sustainable cancer care delivery

Published

October 2020

Citation

McAneny, B, Schwartzberg, L, Koh, W, Arrowsmith, E, Fugaro, A, Haydell, T, Hesketh, PJ, Pudusseri, A, Richey, S, Zarwan, C, Stein, R. . Journal of Clinical Pathways. .

https://www.journalofclinicalpathways.com/article/supporting-optimal-value-based-and-sustainable-cancer-care-delivery

Authors:
McAneny, B, Schwartzberg, L, Koh, W, Arrowsmith, E, Fugaro, A, Haydell, T, Hesketh, PJ, Pudusseri, A, Richey, S, Zarwan, C, Stein, R

Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a successful oncology practice. Additionally, the rising cost of cancer care has contributed to the shift from volume-based to value-based care, often with different payers having different requirements for reporting and reimbursement. Clinical decision support (CDS) systems were developed to help oncologists overcome some of these challenges; however, they have not yet been widely adopted in practice. Through a collaboration between the National Comprehensive Cancer Network (NCCN), Flatiron Health, and oncology practices, an NCCN Guidelines-based CDS system, Flatiron Assist,™ is being piloted as a tool to address some major challenges that oncologists continue to face. Flatiron Assist could help oncology care networks drive standardized care across practices, ease the administrative burden of value-based models, and gather real-world data to better understand costs, quality of care, and patient outcomes, while limiting the need for excessive physician documentation. We also explore persistent barriers to CDS uptake and potential strategies for increasing their utility and use in the field.

Sources:
Journal of Clinical Pathways

Share